Collection: mTOR
Everolimus is recommended for mTOR in gastrointestinal stromal tumors , and no targeted drug has been formally approved
-
Everolimus 5mg Everolimus is a kinase inhibitor indicated for the treatment of: 1. Postmenopausal women with advanced hormone receptor-positive, HER2-negative breast cancer in combination with exemestane after failure of letrozole or anastrozole.
Regular price ¥700.00 CNYRegular priceUnit price / per¥980.00 CNYSale price ¥700.00 CNYSale -
Everolimus 10mg Everolimus is a kinase inhibitor indicated for the treatment of: 1. Postmenopausal women with advanced hormone receptor-positive, HER2-negative breast cancer in combination with exemestane after failure of letrozole or anastrozole.
Regular price ¥1,350.00 CNYRegular priceUnit price / per¥2,000.00 CNYSale price ¥1,350.00 CNYSold out